Form 4: Bausch + Lomb Director Receives Annual Restricted Share Unit Grant

Nathalie D. Bernier, a Director at Bausch + Lomb Corporation, was granted 20,338 restricted share units as part of her annual compensation, vesting prior to the next annual shareholder meeting.

Summary

• Nathalie D. Bernier, a Director of Bausch + Lomb Corporation (BLCO), acquired 20,338 common shares through a grant of restricted share units (RSUs) on May 27, 2025.
• The transaction price for these RSUs was $0, indicating they were granted as compensation rather than purchased.
• These RSUs are part of the annual grant to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated.
• Upon vesting, the RSUs will be settled in common shares, no par value, of Bausch + Lomb Corporation.
• The RSUs are scheduled to vest immediately prior to the company's next annual meeting of shareholders.
• Following this transaction, Ms. Bernier beneficially owns a total of 69,663 common shares directly.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it represents a routine and expected compensation event that aligns director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of restricted share units aligns the interests of Director Nathalie D. Bernier with those of shareholders, as her compensation is tied to the company's stock performance.
• This is a standard practice for compensating non-employee directors, reflecting a routine aspect of corporate governance and executive incentive structures.

Negatives

• The issuance of new shares upon vesting of RSUs will result in a minor dilution of existing shareholder equity, although this is a common and expected aspect of equity compensation plans.

Risks

• The value of the granted restricted share units is subject to the future market price of Bausch + Lomb Corporation's common shares, meaning the actual compensation realized by the director could fluctuate.

Future Outlook

The document indicates that the granted restricted share units are scheduled to vest immediately prior to the next annual meeting of shareholders, implying a future conversion to common shares.

Industry Context

This RSU grant is a standard form of equity compensation for non-employee directors in publicly traded companies across various industries, including the healthcare and pharmaceutical sectors where Bausch + Lomb operates. It reflects common practices for attracting and retaining qualified board members by aligning their financial interests with long-term shareholder value.

Comparison to Industry Standards

• The use of Restricted Share Units (RSUs) for director compensation is a widely adopted practice among S&P 500 companies and global benchmarks, including peers in the healthcare and vision care industry such as Alcon Inc. (ALC) or CooperCompanies (COO), which also utilize equity-based incentives to align director interests with company performance.
• The vesting schedule, tied to the next annual meeting, is a common approach for annual director grants, ensuring continued engagement and oversight through the fiscal year.

Corporate Governance

Related Party Transactions

• The grant of restricted share units to Nathalie D. Bernier, a Director of Bausch + Lomb Corporation, constitutes a related party transaction as it involves compensation provided to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant of RSUs, while aligning director interests, will result in minor future dilution upon vesting and settlement into common shares.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The restricted share units are scheduled to vest immediately prior to the next annual meeting of shareholders, at which point they will be settled in common shares.

Key Dates

Keywords

Bausch + Lomb, BLCO, Restricted Share Units, RSU, Director Compensation, SEC Form 4, Insider Transaction, Equity Compensation, Corporate Governance